Discontinued ProductUnfortunately Statil (Cat. No. 0847) has been withdrawn from sale for commercial reasons.
Potent aldose reductase inhibitor.
Sold with the permission of AstraZeneca UK Ltd.
|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Preparing Stock Solutions
The following data is based on the product molecular weight 391.2. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||2.56 mL||12.78 mL||25.56 mL|
|5 mM||0.51 mL||2.56 mL||5.11 mL|
|10 mM||0.26 mL||1.28 mL||2.56 mL|
|50 mM||0.05 mL||0.26 mL||0.51 mL|
References are publications that support the products' biological activity.
Kador et al (1985) Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications. J.Med.Chem. 28 841 PMID: 3925146
View Related Products by Product Action
Keywords: Statil, supplier, Aldose, reductase, inhibitors, inhibits, Reductases, Carbohydrate, Metabolism, ICI128436, AstraZeneca, ICI-128,436, Aldose, Reductase, Aldose, Reductase, Tocris Bioscience
Citations for Statil
Citations are publications that use Tocris products.
Currently there are no citations for Statil.
Average Rating:(Based on 0 Reviews)
Literature in this Area
New Product Guide (Spring/Summer 2017)New
Our new product guide highlights over 130 new products added to the Tocris Bioscience range during the first half of 2017.
- 7-TM Receptors
- Enzyme-Linked Receptors
- Ion Channels
- Nuclear Receptors
- Cell Metabolism
- Fluorescent Imaging
- Signal Transduction
- Stem Cells